Aer Therapeutics
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
400 W North St Ste 112, Raleigh, North C...Website
www.aertherapeutics.comRevenue
<$5 MillionIndustry
About Aer Therapeutics
AER Therapeutics is focused on improving lung health by targeting mucus obstruction in patients with chronic lung diseases such as COPD and asthma. Their primary product, AER-01, is a novel inhaled therapy designed to liquify mucus plugs, thereby restoring airflow and reducing inflammation. This innovative treatment aims to enhance the effectiveness of existing therapies by allowing them to reach previously blocked areas of the lungs. AER Therapeutics is currently conducting clinical trials to validate the efficacy of AER-01 in treating these conditions.Explore more
SIC Code 28,283NAICS Code 32,325Show moreAer Therapeutics Org Chart
Compare Similar Companies to Aer Therapeutics
Compare insights from companies similar to Aer Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aer Therapeutics Tech Stack
A closer look at the technologies used by Aer Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aer Therapeutics
Sign Up For FreeTo access detailed company insights
AER Therapeutics is focused on improving lung health by targeting mucus obstruction in patients with chronic lung diseases such as COPD and asthma. Their primary product, AER-01, is a novel inhaled therapy designed to liquify mucus plugs, thereby restoring airflow and reducing inflammation. This innovative treatment aims to enhance the effectivenes... Read More
